Diagnosis of EVALI in Adolescents During the COVID-19 Pandemic: A Case Series.
Hosp Pediatr
; 12(5): 538-543, 2022 05 01.
Article
in English
| MEDLINE | ID: covidwho-1779804
ABSTRACT
OBJECTIVE:
Electronic-cigarette or vaping use-associated lung injury (EVALI) is an illness that requires further awareness for appropriate diagnosis and management. This series is a retrospective chart review of EVALI cases admitted from June to December 2020 at a large academic children's hospital in New York.METHODS:
Notably during this time, the coronavirus disease 2019 (COVID-19) global pandemic rendered the world under strict quarantine mandates. We discuss 7 patients, all of whom were seen in a clinic, urgent care, or emergency department before presentation to our hospital.RESULTS:
Patients presented with respiratory, gastroenterology, and constitutional complaints typically seen with EVALI and COVID-19. However, given their complex presentations in the setting of the COVID-19 pandemic, EVALI was not considered as pertinent history was not elicited.CONCLUSIONS:
With the COVID-19 pandemic as a setting for these cases, we emphasize the importance of eliciting a complete psychosocial history for all adolescents because without vaping disclosure, EVALI will go undiagnosed. It is also imperative to ensure consistent outpatient follow-up, although difficult because of limited access or hesitation and fear of acquiring COVID-19 in health care settings during the pandemic, and to stress vaping cessation, both of which are crucial in preventing further complications.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Lung Injury
/
Electronic Nicotine Delivery Systems
/
Vaping
/
COVID-19
Type of study:
Cohort study
/
Diagnostic study
/
Observational study
/
Prognostic study
Limits:
Adolescent
/
Child
/
Humans
Language:
English
Journal:
Hosp Pediatr
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS